What is the appropriate management for cellulitis of the hand?

Management of Hand Cellulitis

For uncomplicated hand cellulitis without systemic signs, treat with oral antibiotics targeting streptococci (such as penicillin, amoxicillin, or cephalexin) for 5 days, combined with elevation and immobilization. 1

Initial Assessment and Risk Stratification

When evaluating hand cellulitis, immediately assess for:

• Systemic signs of infection (fever, tachycardia, hypotension, altered mental status) to determine severity 1
• Purulent drainage, penetrating trauma, or injection drug use which necessitate MRSA coverage 1
• High-risk comorbidities including renal failure and complicated diabetes, which significantly increase outpatient treatment failure (OR 10.2 and 18.29 respectively) 2
• Deep space involvement requiring surgical evaluation, as hand infections can affect subcutaneous tissues, fascia, subfascial spaces, joints, and bone 3, 4

Antibiotic Selection Algorithm

Mild Cellulitis (No Systemic Signs)

• First-line: Oral antibiotics active against streptococci - penicillin, amoxicillin, or cephalexin 1, 5
• Duration: 5 days, extending only if no improvement 1
• MRSA coverage is NOT routinely needed for non-purulent cellulitis despite rising community-acquired MRSA rates 5

Moderate Cellulitis (Systemic Signs Present)

• Consider adding MSSA coverage to streptococcal therapy 1
• Many clinicians appropriately broaden coverage in this scenario 1

Severe Cellulitis (MRSA Risk Factors or SIRS)

• Vancomycin or another agent effective against both MRSA and streptococci is required when: 1
  • Penetrating trauma present
  • Evidence of MRSA infection elsewhere
  • Nasal MRSA colonization documented
  • Injection drug use history
  • Purulent drainage visible
  • Systemic inflammatory response syndrome (SIRS) present

Severely Immunocompromised Patients

• Broad-spectrum coverage with vancomycin PLUS piperacillin-tazobactam or imipenem-meropenem 1
• This applies to patients with malignancy on chemotherapy, neutropenia, or severe cell-mediated immunodeficiency 1

Diagnostic Testing

Cultures are NOT routinely recommended for typical cellulitis cases 1

Obtain blood cultures and consider tissue cultures (aspirates, biopsies, or swabs) when: 1

• Malignancy with chemotherapy
• Neutropenia present
• Severe immunodeficiency
• Immersion injuries
• Animal bites

Obtain plain radiographs in all hand infection cases to evaluate for foreign bodies, gas, or bony involvement 6

Essential Adjunctive Measures

Beyond antibiotics, management requires:

• Elevation of the affected hand to reduce edema 1
• Immobilization to prevent spread and promote healing 3, 4
• Edema control as a critical component 3
• Treatment of predisposing factors such as underlying skin conditions 1
• Examination of interdigital spaces for fissuring, scaling, or maceration that may harbor pathogens 1

Disposition Decisions

Outpatient Management Appropriate When:

• No SIRS present 1
• Normal mental status 1
• Hemodynamically stable 1
• No renal failure or complicated diabetes 2
• Success rate is 97.4% in appropriately selected patients 2

Hospitalization Required When:

• SIRS, altered mental status, or hemodynamic instability present 1
• Concern for deeper or necrotizing infection 1
• Severe immunocompromise 1
• Poor adherence anticipated 1
• Renal failure or complicated diabetes present (high failure risk) 2

Common Pitfalls

Do not empirically cover MRSA in non-purulent cellulitis without specific risk factors, as this represents inappropriate antibiotic stewardship 1, 5

Do not obtain routine cultures in uncomplicated cases, as they have poor sensitivity and rarely change management 1

Do not overlook the need for surgical consultation when deep space infection is suspected, as the complex anatomy of the hand requires specialized knowledge 3, 4

Do not discharge patients with renal disease or complicated diabetes without careful consideration of inpatient therapy given their substantially elevated failure rates 2